0,702  0,024  Caspase 9 stimulant
0,692  0,019  Antineoplastic (lung cancer)
0,688  0,022  Antineoplastic (breast cancer)
0,661  0,007  Caspase 3 stimulant
0,648  0,040  Apoptosis agonist
0,596  0,012  Cardiovascular analeptic
0,555  0,018  Antineoplastic (melanoma)
0,510  0,004  Calcium channel activator
0,521  0,024  Antihypercholesterolemic
0,511  0,026  5 Hydroxytryptamine release stimulant
0,509  0,030  Prostate cancer treatment
0,490  0,012  UGT2B4 substrate
0,493  0,023  Antineoplastic (cervical cancer)
0,510  0,044  TNF expression inhibitor
0,470  0,018  Nitric oxide antagonist
0,471  0,031  Ulceration
0,470  0,040  Antineoplastic (colorectal cancer)
0,465  0,038  Aldehyde oxidase inhibitor
0,465  0,039  Antineoplastic (colon cancer)
0,438  0,030  Antineoplastic (pancreatic cancer)
0,453  0,052  Transcription factor NF kappa B inhibitor
0,430  0,031  CTGF expression inhibitor
0,421  0,023  Tumour necrosis factor alpha release inhibitor
0,432  0,036  FMO1 substrate
0,400  0,012  GST M1-1 substrate
0,400  0,014  5 Hydroxytryptamine uptake stimulant
0,419  0,033  ICAM1 expression inhibitor
0,438  0,053  Antileukemic
0,395  0,016  Antimutagenic
0,386  0,013  Melanin inhibitor
0,431  0,060  5 Hydroxytryptamine release inhibitor
0,400  0,032  NOS2 expression inhibitor
0,416  0,055  CYP2C19 inhibitor
0,393  0,033  Antineoplastic (multiple myeloma)
0,367  0,012  Pneumotoxic
0,391  0,037  UGT1A9 substrate
0,363  0,013  VCAM1 expression inhibitor
0,371  0,021  Abortion inducer
0,381  0,035  Hypoxia-inducible factor 1 alpha inhibitor
0,370  0,029  Antineoplastic (liver cancer)
0,346  0,006  Liver cirrhosis treatment
0,388  0,047  Hepatic disorders treatment
0,380  0,040  Antineoplastic (glioma)
0,353  0,014  Tubulin antagonist
0,374  0,038  Antidiabetic (type 2)
0,401  0,066  Antipruritic, allergic
0,368  0,033  Antineoplastic (glioblastoma multiforme)
0,392  0,058  Vasodilator, peripheral
0,406  0,072  15-Lipoxygenase inhibitor
0,371  0,041  Antioxidant
0,355  0,029  Sigma receptor agonist
0,359  0,033  Chemopreventive
0,339  0,014  Acaricide
0,355  0,031  Antimitotic
0,353  0,032  UGT1A6 substrate
0,341  0,022  P-glycoprotein inhibitor
0,336  0,029  Cyclic AMP phosphodiesterase inhibitor
0,428  0,122  Antiinflammatory
0,329  0,031  Antineoplastic (bladder cancer)
0,352  0,056  Antineoplastic (ovarian cancer)
0,348  0,054  NOS3 expression inhibitor
0,318  0,025  Antihypotensive
0,333  0,042  Cardiodepressant
0,341  0,061  AR expression inhibitor
0,321  0,046  Free radical scavenger
0,324  0,049  Sensitization
0,304  0,030  UGT1A4 substrate
0,279  0,007  UGT2B10 substrate
0,290  0,019  UGT2B15 substrate
0,319  0,048  Cytostatic
0,281  0,011  LDLR expression enhancer
0,289  0,021  CYP2B6 inhibitor
0,288  0,021  Skin whitener
0,296  0,031  Hepatoprotectant
0,282  0,017  Nitric-oxide synthase stimulant
0,286  0,022  Interferon gamma antagonist
0,299  0,035  Septic shock treatment
0,329  0,067  Vasodilator, coronary
0,285  0,029  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,281  0,025  Contraceptive
0,307  0,055  Antineoplastic (non-small cell lung cancer)
0,330  0,082  Antiprotozoal (Plasmodium)
0,261  0,014  Cystathionine beta-synthase inhibitor
0,295  0,050  Vasodilator
0,249  0,005  Postmenopausal disorders treatment
0,300  0,057  Chemoprotective
0,305  0,064  Antiosteoporotic
0,293  0,053  Superoxide dismutase inhibitor
0,277  0,038  UGT1A1 substrate
0,266  0,028  Sepsis treatment
0,314  0,077  Apoptosis antagonist
0,264  0,030  Prostatic (benign) hyperplasia treatment
0,295  0,062  Huntington's disease treatment
0,338  0,105  Histamine release inhibitor
0,272  0,039  RNA-directed DNA polymerase inhibitor
0,279  0,046  5 Hydroxytryptamine 1E antagonist
0,314  0,082  Cholesterol antagonist
0,249  0,020  UGT2B9 substrate
0,263  0,037  UGT2B7 substrate
0,232  0,009  Contraceptive male
0,257  0,034  Neurotrophic factor enhancer
0,305  0,084  Bone diseases treatment
0,299  0,080  Sodium/bile acid cotransporter inhibitor
0,253  0,034  Antipruritic, non-allergic
0,238  0,020  Antifungal enhancer
0,236  0,020  VEGF expression inhibitor
0,235  0,021  Carcinogenic, group 1
0,275  0,064  Antineoplastic (renal cancer)
0,282  0,074  CYP2C19 substrate
0,311  0,105  GST A substrate
0,347  0,141  Antineoplastic (solid tumors)
0,208  0,002  Toll-Like receptor 4 agonist
0,233  0,030  Lipid peroxidase inhibitor
0,267  0,064  Antiamyloidogenic
0,291  0,089  Antineoplastic (small cell lung cancer)
0,221  0,019  Antirickettsial
0,267  0,066  Proliferative diseases treatment
0,213  0,012  Calcium antagonist
0,217  0,019  Arachidonic acid antagonist
0,330  0,138  Cyclophilin D inhibitor
0,330  0,138  Antidiabetic
0,273  0,085  Lipoxygenase inhibitor
0,204  0,017  Cyclooxygenase 3 inhibitor
0,226  0,039  UGT1A3 substrate
0,233  0,048  Myocardial ischemia treatment
0,203  0,019  Microtubule formation inhibitor
0,201  0,021  CF transmembrane conductance regulator agonist
0,204  0,026  Cholesterol synthesis inhibitor
0,214  0,037  Protein kinase stimulant
0,250  0,076  Antipyretic
0,184  0,010  Inducible nitric-oxide synthase inhibitor
0,212  0,040  Succinate dehydrogenase inhibitor
0,246  0,075  Antiprotozoal (Leishmania)
0,337  0,166  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,176  0,007  UGT2B11 substrate
0,188  0,021  Beta amyloid protein antagonist
0,184  0,017  Photosensitizer
0,201  0,035  Genotoxic
0,248  0,082  Gastrin inhibitor
0,202  0,037  Heat shock protein 90 antagonist
0,241  0,077  Tyrosine 3 hydroxylase inhibitor
0,286  0,125  GABA C receptor rho-3 antagonist
0,203  0,043  Amylase inhibitor
0,206  0,048  Antineoplastic (gastric cancer)
0,176  0,020  Vanilloid 1 agonist
0,278  0,124  CYP2C9 substrate
0,279  0,125  Toll-Like receptor agonist
0,253  0,100  Respiratory analeptic
0,190  0,037  Antiprotozoal (Coccidial)
0,188  0,037  Acetylcholinesterase inhibitor
0,285  0,135  Antiprotozoal
0,161  0,013  Antifungal (Pneumocystis)
0,247  0,100  Insulysin inhibitor
0,175  0,029  Antihelmintic (Trematoda)
0,171  0,026  Coagulant
0,165  0,022  Heat shock protein 70 antagonist
0,230  0,088  Antineoplastic (sarcoma)
0,218  0,076  Antiparasitic
0,162  0,021  Ca2+-transporting ATPase inhibitor
0,227  0,086  Acute neurologic disorders treatment
0,227  0,086  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,157  0,016  Antiprotozoal (Toxoplasma)
0,186  0,046  Antineoplastic (squamous cell carcinoma)
0,145  0,005  Aldosterone antagonist
0,190  0,050  Toxic, respiratory center
0,215  0,075  Antiparkinsonian, rigidity relieving
0,155  0,015  Anabolic
0,173  0,034  Antifungal (Cryptococcus)
0,235  0,096  Transcription factor STAT3 inhibitor
0,188  0,050  Antiviral (Influenza A)
0,177  0,039  Anesthetic local
0,241  0,106  CYP1A2 substrate
0,230  0,096  Cardiotonic
0,177  0,044  GABA C receptor rho-2 antagonist
0,139  0,006  5 Hydroxytryptamine 2A agonist
0,234  0,102  CYP1A2 inhibitor
0,190  0,058  3C-like protease (Human coronavirus) inhibitor
0,142  0,012  Glutamate release inhibitor
0,197  0,067  5 Hydroxytryptamine 3E antagonist
0,226  0,098  Interleukin agonist
0,204  0,076  Cytotoxic
0,187  0,061  Tumour necrosis factor antagonist
0,182  0,056  Phobic disorders treatment
0,255  0,129  CYP3A4 substrate
0,155  0,029  Mucolytic
0,249  0,124  Angiogenesis inhibitor
0,154  0,030  Antineoplastic (uterine cancer)
0,148  0,024  Estrogen antagonist
0,268  0,144  CYP2C9 inhibitor
0,198  0,076  Anesthetic general
0,145  0,024  Carcinogenic, group 2A
0,162  0,041  Protein-tyrosine phosphatase 1B inhibitor
0,124  0,004  Glutamate (mGluR7) antagonist
0,129  0,011  Granulocyte macrophage colony stimulating factor agonist
0,242  0,125  Antineoplastic (brain cancer)
0,142  0,025  Electron transport complex I inhibitor
0,129  0,013  Estrogen agonist
0,124  0,009  Transcription factor AP-1 inhibitor
0,173  0,058  Neurotensin receptor agonist
0,150  0,035  SULT1A1 substrate
0,191  0,077  Antiviral (Ebola)
0,149  0,035  Contraceptive female
0,176  0,062  ATPase inhibitor
0,187  0,074  Antihelmintic
0,147  0,034  Choleretic
0,128  0,016  Beta tubulin antagonist
0,178  0,066  Peroxidase inhibitor
0,154  0,043  Antihemorrhagic
0,145  0,034  TRPA1 agonist
0,165  0,054  Anesthetic
0,217  0,107  Spasmolytic
0,171  0,062  Cholinergic
0,172  0,064  Prostate disorders treatment
0,154  0,046  Pregnane X receptor agonist
0,141  0,033  UGT2B1 substrate
0,116  0,009  Dopamine transporter inhibitor
0,119  0,013  Alpha tubulin antagonist
0,155  0,051  NADPH oxidase inhibitor
0,209  0,104  Hypoglycemic
0,156  0,053  Adenylate cyclase stimulant
0,142  0,039  Expectorant
0,219  0,116  Cardioprotectant
0,144  0,042  Alpha 2b adrenoreceptor antagonist
0,107  0,005  Transcription factor RelA inhibitor
0,115  0,014  Glycine receptor agonist
0,132  0,032  Breast cancer-resistant protein inhibitor
0,173  0,073  Antineoplastic (bone cancer)
0,175  0,076  Antianginal
0,134  0,034  Beta glucuronidase inhibitor
0,137  0,039  Alpha 2c adrenoreceptor antagonist
0,130  0,032  Nitric-oxide synthase inhibitor
0,137  0,039  GST P1-1 substrate
0,156  0,059  SULT1A3 substrate
0,164  0,067  Protein-tyrosine phosphatase inhibitor
0,235  0,139  Antithrombotic
0,132  0,035  Dementia treatment
0,128  0,031  GST T1-1 substrate
0,271  0,175  Alpha-glucosidase inhibitor
0,220  0,125  CYP2D6 substrate
0,117  0,022  Keratolytic
0,202  0,108  Vascular (periferal) disease treatment
0,154  0,061  Mannose-6-phosphate isomerase inhibitor
0,171  0,079  Lipocortins synthesis antagonist
0,160  0,069  Diuretic
0,147  0,057  Nav1.6 sodium channel blocker
0,119  0,029  Phosphodiesterase 4D inhibitor
0,223  0,132  FMO3 substrate
0,125  0,036  Vascular dementia treatment
0,094  0,007  Calcium channel P-type blocker
0,130  0,043  GABA C receptor antagonist
0,126  0,039  Acetylcholine release stimulant
0,143  0,057  Toll-Like receptor 2 antagonist
0,226  0,140  CYP3A4 inhibitor
0,138  0,052  Monophenol monooxygenase inhibitor
0,133  0,047  Carcinogenic, group 2B
0,109  0,025  Vanilloid agonist
0,102  0,022  Narcotic antagonist
0,115  0,036  Glutamate (mGluR7) agonist
0,083  0,005  5 Hydroxytryptamine 2B agonist
0,107  0,030  ATPase (Vacuolar H+) inhibitor
0,206  0,130  Analeptic
0,085  0,010  5 Hydroxytryptamine 2C agonist
0,105  0,029  Phosphodiesterase 3A inhibitor
0,083  0,008  Ryanodine receptor antagonist
0,089  0,015  SULT2A1 substrate
0,109  0,035  Ornithine decarboxylase inhibitor
0,135  0,062  Antiseptic
0,176  0,102  Antihypertriglyceridemic
0,109  0,036  Antidote, mercury
0,086  0,013  5 Hydroxytryptamine 2 agonist
0,120  0,048  Nav1.1 sodium channel blocker
0,081  0,010  Anesthetic inhalation
0,133  0,062  Antismoking
0,152  0,083  Uterine stimulant
0,096  0,027  Calcium channel L-type blocker
0,138  0,070  Calcium channel blocker
0,169  0,101  Psychostimulant
0,108  0,040  Toll-Like receptor 3 antagonist
0,081  0,013  Postcoital contraceptive
0,107  0,040  Phosphodiesterase IV inhibitor
0,182  0,115  Antineoplastic (lymphocytic leukemia)
0,112  0,045  Antifungal (Aspergillus)
0,111  0,045  Prolactin inhibitor
0,105  0,039  Phosphodiesterase I inhibitor
0,075  0,010  Pregnane X receptor antagonist
0,192  0,129  Radioprotector
0,097  0,035  Glycine receptor antagonist
0,197  0,135  Flavin-containing monooxygenase substrate
0,088  0,027  Hyperparathyroidism treatment
0,096  0,035  Na+ K+ transporting ATPase inhibitor
0,187  0,127  DNA damaging
0,066  0,007  Guanylate cyclase inhibitor
0,162  0,103  Antiviral (Influenza)
0,086  0,027  Anticholelithogenic
0,081  0,023  Androgen agonist
0,098  0,041  Tocolytic
0,093  0,036  Estrogen-related receptor beta agonist
0,107  0,051  Estrogen receptor beta antagonist
0,121  0,065  Antiviral (Influenza B)
0,154  0,097  Catenin beta inhibitor
0,191  0,137  DNA synthesis inhibitor
0,111  0,057  DOPA decarboxylase inhibitor
0,101  0,048  SULT1E1 substrate
0,094  0,041  mTOR complex 2 inhibitor
0,196  0,144  Transcription factor STAT inhibitor
0,061  0,009  Endothelin receptor antagonist
0,056  0,005  Endothelin B receptor antagonist
0,107  0,056  Sulfotransferase substrate
0,119  0,068  Topoisomerase II inhibitor
0,088  0,037  Estrogen receptor alpha antagonist
0,078  0,027  Glutamate (mGluR6) antagonist
0,144  0,094  Heat shock protein 90 alpha antagonist
0,078  0,028  Exportin-1 inhibitor
0,066  0,016  Mineralocorticoid receptor antagonist
0,112  0,063  5 Hydroxytryptamine 3A agonist
0,126  0,078  Antiprotozoal (Trichomonas)
0,140  0,092  Neuropathy treatment
0,061  0,014  Progesterone antagonist
0,084  0,038  Antidote, organophosphates
0,201  0,156  Prostaglandin dehydrogenase inhibitor
0,072  0,027  Phosphodiesterase 1C inhibitor
0,195  0,150  Antidepressant
0,073  0,028  Antimycoplasmal
0,124  0,079  Nav1.2 sodium channel blocker
0,078  0,034  Dopamine D1 antagonist
0,196  0,152  Antifungal
0,101  0,057  Tourette's syndrome treatment
0,150  0,106  Platelet adhesion inhibitor
0,083  0,040  CDC25A inhibitor
0,097  0,055  Bile acid receptor antagonist
0,073  0,030  Protease activated receptor antagonist
0,074  0,031  Adrenaline uptake inhibitor
0,136  0,094  Raynaud's phenomenon treatment
0,095  0,054  Paget's disease treatment
0,120  0,079  Antihyperlipoproteinemic
0,128  0,087  Antineoplastic (carcinoma)
0,067  0,026  Phosphodiesterase 4A inhibitor
0,052  0,012  Kainate receptor agonist
0,103  0,064  GABA C receptor agonist
0,210  0,171  Antineoplastic (osteosarcoma)
0,104  0,065  HDL-cholesterol increasing
0,096  0,058  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,048  0,009  Nucleoside transporters inhibitor
0,133  0,095  Neuropeptide Y1 antagonist
0,085  0,047  NAD(P)H dehydrogenase (quinone) inhibitor
0,148  0,111  Phospholipase C inhibitor
0,049  0,013  Histone deacetylase 4 inhibitor
0,075  0,039  Phosphodiesterase III inhibitor
0,076  0,041  Orexin receptor 1 antagonist
0,117  0,083  Gastritis treatment
0,094  0,060  Alpha 2d adrenoreceptor antagonist
0,074  0,040  Acetylcholine M5 receptor agonist
0,063  0,030  Lipocortins synthesis agonist
0,089  0,056  Alpha 2 adrenoreceptor antagonist
0,115  0,083  Alpha-N-acetylglucosaminidase inhibitor
0,085  0,054  Antineoplastic antibiotic
0,118  0,087  Sodium channel (voltage-gated) blocker
0,109  0,078  Alkylator
0,090  0,059  Actinic keratosis treatment
0,143  0,112  DNA methyltransferase I inhibitor
0,070  0,040  Orexin receptor antagonist
0,066  0,037  Aromatase inhibitor
0,189  0,160  CYP2D6 inhibitor
0,192  0,164  Mood disorders treatment
0,040  0,012  Adenosine uptake inhibitor
0,109  0,081  Shock treatment
0,129  0,102  Phospholipase A2 inhibitor
0,077  0,050  Antitreponemal
0,040  0,013  Cholesterol ester transfer protein antagonist
0,094  0,068  Antifungal (Candida)
0,035  0,009  Endothelin A receptor antagonist
0,166  0,140  ErbB-1 antagonist
0,043  0,017  Antihyperaldosteronism
0,128  0,102  Eye irritation, high
0,078  0,052  Nicotinic alpha4beta2 receptor antagonist
0,042  0,017  Vanilloid 3 antagonist
0,033  0,009  Hedgehog signaling activator
0,075  0,052  Alpha 2a adrenoreceptor antagonist
0,038  0,015  Melatonin receptor 1A agonist
0,240  0,217  Calcium channel L-type activator
0,075  0,054  Carbonic anhydrase XIII inhibitor
0,093  0,072  Chronic obstructive bronchitis treatment
0,187  0,166  12-Lipoxygenase inhibitor
0,095  0,074  Carbonic anhydrase XV inhibitor
0,084  0,063  Antileprosy
0,049  0,029  CC chemokine 4 receptor antagonist
0,223  0,203  Antibacterial
0,043  0,024  Dopamine D5 agonist
0,042  0,023  Alpha 1d adrenoreceptor agonist
0,157  0,138  Antialcoholic
0,038  0,020  Glucocorticoid antagonist
0,040  0,022  Glutamate (mGluR8) agonist
0,037  0,019  Tubulin agonist
0,029  0,011  Vanilloid 2 agonist
0,035  0,017  Endothelial nitric-oxide synthase inhibitor
0,076  0,059  MAP kinase kinase 7 inhibitor
0,113  0,097  Cocaine dependence treatment
0,086  0,070  HIV-1 integrase (Overall Integration) inhibitor
0,045  0,029  Glutamate (mGluR group III) antagonist
0,031  0,016  Nicotinic alpha4beta2 receptor agonist
0,025  0,010  Imidazoline I1 receptor antagonist
0,021  0,006  NMDA receptor phencyclidine site antagonist
0,091  0,076  GABA C receptor rho-1 antagonist
0,052  0,037  Alpha 1L adrenoreceptor antagonist
0,141  0,126  DNA methylase inhibitor
0,178  0,163  Radiosensitizer
0,058  0,044  Heat shock protein 90 beta antagonist
0,063  0,049  Purinergic P2X2 antagonist
0,032  0,018  Nicotinic alpha3beta4 receptor agonist
0,109  0,096  Sphingosine 1-phosphate receptor 4 antagonist
0,128  0,115  Carcinogenic
0,033  0,020  Glutamate (mGluR3) agonist
0,034  0,021  Melatonin agonist
0,037  0,024  Orexin receptor 2 antagonist
0,077  0,065  Antispirochetal
0,149  0,137  Hypolipemic
0,082  0,070  NADH dehydrogenase inhibitor
0,034  0,022  Melatonin 2 agonist
0,131  0,120  Antipruritic
0,033  0,023  Melatonin 1 agonist
0,032  0,022  Histone deacetylase class IIa inhibitor
0,062  0,052  Uterine relaxant
0,114  0,105  Activin receptor-like kinase 2 inhibitor
0,079  0,070  D-Ala-D-Ala ligase inhibitor
0,077  0,069  Androgen antagonist
0,065  0,056  MDM2 inhibitor
0,053  0,045  5 Hydroxytryptamine 7 agonist
0,079  0,071  T cell inhibitor
0,044  0,036  Potassium channel Kv1.3 blocker
0,136  0,129  UDP-glucuronosyltransferase substrate
0,137  0,129  Hearing loss treatment
0,056  0,049  5 Hydroxytryptamine uptake inhibitor
0,106  0,099  Antiprotozoal (Amoeba)
0,110  0,103  Antianorexic
0,077  0,071  Antiviral (Trachoma)
0,088  0,082  Phosphodiesterase 6D inhibitor
0,076  0,071  Antineoplastic alkaloid
0,060  0,055  Beta adrenoreceptor antagonist
0,094  0,089  Multidrug resistance-associated protein 1 inhibitor
0,017  0,012  Free fatty acid receptor 1 agonist
0,023  0,019  Sodium/glucose cotransporter 1 inhibitor
0,021  0,017  GRP78 expression inhibitor
0,037  0,033  Estradiol 17 beta-dehydrogenase inhibitor
0,084  0,080  Sphingomyelinase inhibitor
0,054  0,051  Phosphodiesterase 1B inhibitor
0,056  0,053  5 Hydroxytryptamine 5A antagonist
0,068  0,066  Phosphodiesterase VI inhibitor
0,065  0,062  Antibiotic
0,048  0,046  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,135  0,132  Aldehyde oxidase substrate
0,009  0,007  Progesterone receptor A antagonist
0,085  0,083  Antiviral (Hepatitis A)
0,011  0,010  Melatonin 2 antagonist
0,013  0,011  Melatonin receptor 1A antagonist
0,050  0,049  Dopamine uptake inhibitor
0,136  0,136  I kappa B kinase epsilon inhibitor
0,109  0,108  Antiparkinsonian, tremor relieving

